Patents by Inventor Yann Lamotte

Yann Lamotte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW MACROCYCLIC LRRK2 KINASE INHIBITORS
    Publication number: 20230357269
    Abstract: Compounds of Formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 9, 2023
    Inventors: Petra Marcella BLOM, Christopher Gaètan HOUSSEMAN, Alain DAUGAN, Audrey DUMOULIN, Maxime LAUGEOIS, Alexis DENIS, Nicolas FAUCHER, Iuliana BOTEZ, Arnaud LE TIRAN, Kenneth CHRISTENSEN, Yann LAMOTTE
  • MACROCYCLIC RIP2-KINASE INHIBITORS
    Publication number: 20230126352
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2-kinase, and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
    Type: Application
    Filed: February 1, 2021
    Publication date: April 27, 2023
    Applicant: Oncodesign SA
    Inventors: Yann LAMOTTE, Nérina DODIC, Aurélien TAP, Alexis DENIS, Jean-Marie BRUSO, Mourad DAOUBI KHAMLICHI, Pascal André Rene PENDERITTER
  • Quinolinone derivatives
    Patent number: 9855260
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: January 2, 2018
    Assignee: GLAXOSMITHKLINE LLC
    Inventors: Alain Claude-Marie Daugan, Yann Lamotte, Olivier Mirguet
  • QUINOLINONE DERIVATIVES
    Publication number: 20150238480
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Application
    Filed: May 11, 2015
    Publication date: August 27, 2015
    Inventors: Alain Claude-Marie DAUGAN, Yann LAMOTTE, Olivier MIRGUET
  • Quinolinone derivatives
    Patent number: 9061998
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: June 23, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Alain Claude-Marie Daugan, Olivier Mirguet, Yann Lamotte
  • QUINOLINONE DERIVATIVES
    Publication number: 20130345212
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Application
    Filed: March 5, 2012
    Publication date: December 26, 2013
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Alain Claude-Marie Daugan, Olivier Mirguet, Yann Lamotte
  • 1H-PYROLLO[3,2-D]PYRIMIDINEDIONE DERIVATIVES
    Publication number: 20130345243
    Abstract: The present invention relates to pyrimidinedione compounds of formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds of formula (I) or salts thereof as activators of AMPK.
    Type: Application
    Filed: March 5, 2012
    Publication date: December 26, 2013
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Claude-Marie Daugan, Yann Lamotte, Olivier Mirguet
  • Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors
    Patent number: 8557984
    Abstract: Novel compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: October 15, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Anne Marie Jeanne Bouillot, Frederic Donche, Francoise Jeanne Gellibert, Yann Lamotte, Olivier Mirguet
  • Imidazo [4, 5-C] Quinoline Derivatives As Bromodomain Inhibitors
    Publication number: 20120232074
    Abstract: Novel compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
    Type: Application
    Filed: November 3, 2010
    Publication date: September 13, 2012
    Inventors: Anne Marie Jeanne Bouillot, Frederic Donche, Francoise Jeanne Gellibert, Yann Lamotte, Olivier Mirguet
  • THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE
    Publication number: 20100120669
    Abstract: The present invention relates to substituted thiadiazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: February 26, 2008
    Publication date: May 13, 2010
    Inventors: Anne Marie Jeanne Bouillot, Thierry Boyer, Alain Claude-Marie Daugan, Anthony William Dean, Martin Christian Fillmore, Yann Lamotte